N-(Pyrimidin-4-yl) and N-(Pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists
摘要:
The SAR studies to optimise both potency and rate of clearance in the rat for a series of pyrimidine and pyridine based VLA-4 antagonists are described. (C) 2002 Elsevier Science Ltd. All rights reserved.
Phenylalanine derivatives as alpha 4 integrin inhibitors
申请人:——
公开号:US20020055509A1
公开(公告)日:2002-05-09
Disclosed are a series of phenylalanine derivatives, to compositions containing them, to processes for their preparation, and to their use in medicine.
本发明涉及一系列苯丙氨酸衍生物,涉及含有它们的组合物,涉及它们的制备过程以及它们在医学中的使用。
PHENYLALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS
申请人:CELLTECH THERAPEUTICS LIMITED
公开号:EP1117657A1
公开(公告)日:2001-07-25
US6689781B2
申请人:——
公开号:US6689781B2
公开(公告)日:2004-02-10
US7291645B2
申请人:——
公开号:US7291645B2
公开(公告)日:2007-11-06
[EN] PHENYLALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS<br/>[FR] DERIVES DE PHENYLALANINE COMME INHIBITEURS D'ALPHA 4 INTEGRINE
申请人:CELLTECH THERAPEUTICS LTD
公开号:WO2000018759A1
公开(公告)日:2000-04-06
Phenylalanine derivatives of formula (1) are described in which: Ar1 is an aromatic or heteroaromatic group; L1 is a linker atom or group; R is a carboxylic acid or a derivative thereof; Ar2 is an optionally substituted aromatic or heteroaromatic group; and the salts, solvates, hydrates and N-oxides thereof. The compounds are able to inhibit the binding of α4 integrins to their ligands and are of use in the prophylaxis and treatment of immune or inflammatory disorders.